We therefore subsequently examined the N-terminus of CTNND1 transcripts in more detail in mRNA samples of a cohort of 96 breast cancer patients using variant-encompassing primers spanning the 5’ region containing the alternative entry points (Figure S1B). The gene discussed is CTNND1; the disease is breast cancer.